Sign Out
XYNTHA, Antihemophilic factor (Recombinant), is indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for: On-demand treatment and control of bleeding episodes; Perioperative management; Routine prophylaxis to reduce the frequency of bleeding episodes.
XYNTHA does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
Continue with Google